New wrinkle between cancer and blood coagulation: metastasis and cleavage of von Willebrand factor by ADAM28.
作者信息
Zucker Stanley, Cao Jian
出版信息
J Natl Cancer Inst. 2012 Jun 20;104(12):887-8. doi: 10.1093/jnci/djs251. Epub 2012 May 25.
Abstract
摘要
相似文献
1
New wrinkle between cancer and blood coagulation: metastasis and cleavage of von Willebrand factor by ADAM28.癌症与血液凝固之间的新难题：ADAM28介导的血管性血友病因子转移与裂解
J Natl Cancer Inst. 2012 Jun 20;104(12):887-8. doi: 10.1093/jnci/djs251. Epub 2012 May 25.
2
Re: Effect of ADAM28 on carcinoma cell metastasis by cleavage of von Willebrand factor.回复：ADAM28通过裂解血管性血友病因子对癌细胞转移的影响。
J Natl Cancer Inst. 2012 Dec 19;104(24):1917; author reply 1917-8. doi: 10.1093/jnci/djs459. Epub 2012 Nov 6.
3
Effect of ADAM28 on carcinoma cell metastasis by cleavage of von Willebrand factor.ADAM28 通过切割血管性血友病因子影响癌细胞转移。
J Natl Cancer Inst. 2012 Jun 20;104(12):906-22. doi: 10.1093/jnci/djs232. Epub 2012 May 25.
4
ADAM28 from both endothelium and gastric cancer cleaves von Willebrand Factor to eliminate von Willebrand Factor-induced apoptosis of gastric cancer cells.来自内皮细胞和胃癌的 ADAM28 裂解血管性血友病因子以消除血管性血友病因子诱导的胃癌细胞凋亡。
Eur J Pharmacol. 2021 May 5;898:173994. doi: 10.1016/j.ejphar.2021.173994. Epub 2021 Mar 3.
5
[Research advances on ADAM28 expression and ADAM28-mediated tumor metastasis].[ADAM28表达及ADAM28介导的肿瘤转移研究进展]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Aug;22(4):1142-7. doi: 10.7534/j.issn.1009-2137.2014.04.049.
6
Response to letter regarding article, "plasmin cleavage of von willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy".对关于文章《纤溶酶切割血管性血友病因子作为血栓性微血管病中ADAMTS13缺乏的紧急旁路》的来信的回复
Circulation. 2015 Jan 13;131(2):e19-20. doi: 10.1161/CIRCULATIONAHA.114.012802.
7
Letter by Hugenholtz and Lisman regarding article, "plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy".休根霍兹和利兹曼就文章《纤溶酶对血管性血友病因子的切割作为血栓性微血管病中ADAMTS13缺乏的紧急旁路》所写的信。
Circulation. 2015 Jan 13;131(2):e18. doi: 10.1161/CIRCULATIONAHA.114.009307.
8
In vivo von Willebrand factor size heterogeneity in spite of the clinical deficiency of ADAMTS-13.尽管存在ADAMTS-13临床缺陷，但体内血管性血友病因子大小存在异质性。
J Thromb Haemost. 2011 Dec;9(12):2506-8. doi: 10.1111/j.1538-7836.2011.04519.x.
9
ADAMTS13 and von Willebrand factor assessment before and after kidney transplantation.肾移植前后的ADAMTS13和血管性血友病因子评估
Clin Chim Acta. 2011 Nov 20;412(23-24):2353-4. doi: 10.1016/j.cca.2011.08.034. Epub 2011 Sep 3.
10
von Willebrand factor, shear stress, and ADAMTS13 in hemostasis and thrombosis.血管性血友病因子、切应力和 ADAMTS13 在止血和血栓形成中的作用。
ASAIO J. 2012 Mar-Apr;58(2):163-9. doi: 10.1097/MAT.0b013e31824363e7.
引用本文的文献
1
Oncogenic ADAM28 induces gemcitabine resistance and predicts a poor prognosis in pancreatic cancer.致癌性 ADAM28 诱导吉西他滨耐药并预测胰腺癌预后不良。
World J Gastroenterol. 2019 Oct 7;25(37):5590-5603. doi: 10.3748/wjg.v25.i37.5590.
2
Early and late endothelial response in breast cancer metastasis in mice: simultaneous quantification of endothelial biomarkers using a mass spectrometry-based method.早期和晚期乳腺癌转移小鼠的内皮反应：使用基于质谱的方法同时定量内皮生物标志物。
Dis Model Mech. 2019 Mar 1;12(3):dmm036269. doi: 10.1242/dmm.036269.
3
Increased von Willebrand factor over decreased ADAMTS-13 activity is associated with poor prognosis in patients with advanced non-small-cell lung cancer.血管性血友病因子升高而ADAMTS-13活性降低与晚期非小细胞肺癌患者的不良预后相关。
J Clin Lab Anal. 2018 Jan;32(1). doi: 10.1002/jcla.22219. Epub 2017 Apr 4.
4
Increased international normalized ratio level in hepatocellular carcinoma patients with diabetes mellitus.肝癌合并糖尿病患者的国际标准化比值升高。
World J Gastroenterol. 2013 Apr 21;19(15):2395-403. doi: 10.3748/wjg.v19.i15.2395.
本文引用的文献
1
Effect of ADAM28 on carcinoma cell metastasis by cleavage of von Willebrand factor.ADAM28 通过切割血管性血友病因子影响癌细胞转移。
J Natl Cancer Inst. 2012 Jun 20;104(12):906-22. doi: 10.1093/jnci/djs232. Epub 2012 May 25.
2
Molecular networks that regulate cancer metastasis.调控癌症转移的分子网络。
Semin Cancer Biol. 2012 Jun;22(3):234-49. doi: 10.1016/j.semcancer.2012.03.006. Epub 2012 Mar 30.
3
The clinical value of von Willebrand factor in colorectal carcinomas.结直肠癌中血管性血友病因子的临床价值。
Am J Transl Res. 2011;3(5):445-53. Epub 2011 Sep 23.
4
ABO blood group and cancer.ABO 血型与癌症。
Eur J Cancer. 2010 Dec;46(18):3345-50. doi: 10.1016/j.ejca.2010.08.009.
5
Role of von Willebrand factor in tumor metastasis.血管性血友病因子在肿瘤转移中的作用。
Thromb Res. 2007;120 Suppl 2:S64-70. doi: 10.1016/S0049-3848(07)70132-9.
6
ADAMs in cancer cell proliferation and progression.ADAMs在癌细胞增殖和进展中的作用。
Cancer Sci. 2007 May;98(5):621-8. doi: 10.1111/j.1349-7006.2007.00434.x. Epub 2007 Mar 9.
7
Insights into von Willebrand factor proteolysis: clinical implications.
Br J Haematol. 2006 Jun;133(5):457-67. doi: 10.1111/j.1365-2141.2006.06096.x.
8
Cancer as a chronic illness? Reconsidering categorization and exploring experience.癌症是一种慢性病？重新审视分类并探索相关体验。
Eur J Cancer Care (Engl). 2002 Sep;11(3):161-5. doi: 10.1046/j.1365-2354.2002.00345.x.
9
Intravascular location of breast cancer cells after spontaneous metastasis to the lung.乳腺癌细胞自发转移至肺后在血管内的定位。
Am J Pathol. 2002 Sep;161(3):749-53. doi: 10.1016/S0002-9440(10)64233-2.
10
Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.基质金属蛋白酶抑制剂在癌症治疗中应用的批判性评价。
Oncogene. 2000 Dec 27;19(56):6642-50. doi: 10.1038/sj.onc.1204097.
Zotero 插件